Objectif This Marie Curie Excellence Grant proposal by team Leader N. Callewert focuses on the application of a technology core for the isolation, analysis and bioengineering of mannosylated glycoconjugates. This technology core is now sufficiently advanced to explore its utility in tackling a number of long-standing biomedical and biotechnological challenges: vaccine design, genomic analysis of pathogen glycoconjugate biosynthesis pathways, and production of sufficient quantities of homogenously glycosylated proteins for structural analysis. Champ scientifique medical and health sciencesbasic medicineimmunologyimmunisationnatural sciencesbiological sciencesmicrobiologyvirologynatural sciencesbiological sciencesbiochemistrybiomoleculesproteinsmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccinesnatural sciencesbiological sciencesbiochemistrybiomoleculescarbohydrates Programme(s) FP6-MOBILITY - Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006 Thème(s) MOBILITY-3.1 - Marie Curie Excellence Grants (EXT) Appel à propositions FP6-2002-MOBILITY-8 Voir d’autres projets de cet appel Régime de financement EXT - Marie Curie actions-Grants for Excellent Teams Coordinateur FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW Contribution de l’UE Aucune donnée Adresse Rijvisschestraat 120 ZWIJNAARDE Belgique Voir sur la carte Liens Site web Opens in new window Coût total Aucune donnée